title: Isolated common peroneal nerve palsy in sarcoidosis.
abstract: Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology, characterized pathologically by the presence of noncaseating epithelioid granulomas. Estimated prevalence of sarcoidosis is 10-20 per 100,000 populations, 3-4 times more common in blacks, presents between the ages of 10-40 years in (70-90)% of cases. Sarcoid neuropathy is one of the rare conditions. It involves approximately 5% of sarcoid patients. Many forms of involvement were reported e.g.; facial nerve palsy, multifocal sensory or motor polyneuropathy or very rarely Guillain Barre' like syndrome. In one clinical series it was estimated that only 10% had primarily peripheral nerve or muscle lesions, where as 90% had primarily CNS or cranial nerve lesions.
authors.affiliation: Department of General Medicine, Sligo General Hospital, Sligo.
authors.forename: J
authors.initials: J
authors.lastname: Mckenna
authors.forename: A
authors.initials: A
authors.lastname: Ibrahim
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010543:Peroneal Nerve / Q000473:pathology*; D020427:Peroneal Neuropathies / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D011239:Prednisolone